Aibafang Group CO., Ltd. (FONG)
Aibafang Group CO. will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Company Description

Aibafang Group is a leading research and development, manufacturer and distributor of Chinese medicine and healthcare products, and also have built an industry-leading digital platform for healthcare products and services.

Aibafang Mall is our e-commerce platform where we interact with our consumers and launch new products.

We have diversified products lines, covering all age groups of customers and different needs of the population.

The products mainly include pain series, detoxification series, beauty and skin care series, men’s health series and gynecological series.

We also launched our first software, Hushenbao app, which is records of more than 1,000 kinds of disease treatment methods, Chinese medicine prescription, you can search for the disease symptomatic treatment, but also online consultation directly, Chinese medicine professionals 24/7 for customer service.

Our offline stores and operation centers are located throughout China, totally 19 provinces and regions as well as overseas.

Aibafang Group CO., Ltd.
Country Cayman Islands
Industry Pharmaceutical Retailers
Sector Healthcare
CEO Ping Song

Contact Details

Address:
Suite # 4-210 Governors Square,23 Lime Tree Bay Avenue
Grand Cayman, KY1-1209
Cayman Islands
Phone 345 945-7676

Stock Details

Ticker Symbol FONG
Exchange NASDAQ
Reporting Currency USD
CIK Code 0001999161
SIC Code 2834

Key Executives

Name Position
Ping Song Chairman of the Board,Chief Executive Officer and Director
Xurong Bai Vice President and Director
Xiaohong Song Chief Financial Officer and Director
Zhuping Huang Chief Technology Officer and Director
Yuping Peng Chief Information Officer
Guoyong Ran Chief Marketing Officer
Xiaoyang Song Independent Director

Latest SEC Filings

Date Type Title
Oct 30, 2023 F-1 Registration statement for certain foreign private issuers